Get the latest news on Helius Medical Tech stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on HSDTW performance

Latest Helius Medical Tech Stock News | OTC:HSDTW | Benzinga

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

Helius Medical Technologies Inc Warrants (02/02/2026)

Comments

Helius Medical Tech Stock News

News

Latest Helius Medical Tech Stock News | OTC:HSDTW | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga